Overcoming the AAV Capacity Challenge
Time: 9:00 am
day: Delivery Stream 1
- An overview of the gene-carrying capacities of commonly used vectors in ocular gene therapy delivery
- Acknowledging the limited packaging size of AAV vectors, what are the benefits and drawbacks of dual AAV approaches?
- Exploring protein splicing AAV gene therapy for large gene delivery, and their potential benefits
- Understanding novel, non-viral, large-gene delivery approaches, their potential benefits as well as toxicity challenges